PS1068 SAFETY ANALYSIS OF AUSTRALASIAN LEUKAEMIA & LYMPHOMA GROUP NHL29: A PHASE II STUDY OF IBRUTINIB, RITUXIMAB AND MINI-CHOP IN VERY ELDERLY PATIENTS WITH NEWLY DIAGNOSED DIFFUSE LARGE B CELL LYMPHOMA

Autor:	Anoop K Enjeti, B.E. Butcher, Christina Brown, Jennifer Curnow, J. Trotman, Robin Filshie, Amanda Johnston, E. Verner, N. Pati, H.P. Lee, S. Cake, Tara Cochrane, Duncan Purtill, H. Sia, C.Y. Cheah, Nichloas Murphy, E. Hawkes, J. Carlson
Rok vydání:	2019
Předmět:	Oncology medicine.medical_specialty business.industry Phases of clinical research Hematology Newly diagnosed CHOP medicine.disease Lymphoma chemistry.chemical_compound chemistry Internal medicine Ibrutinib Medicine Rituximab business Diffuse large B-cell lymphoma medicine.drug
Zdroj:	HemaSphere. 3:483-484
ISSN:	2572-9241
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::9d4f582179704f22132195e0f6c372a9 https://doi.org/10.1097/01.hs9.0000562568.25368.82 Zobrazit plný text záznamu Plný text